X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (117318) 117318
Publication (5273) 5273
Magazine Article (775) 775
Book Review (328) 328
Book / eBook (185) 185
Book Chapter (112) 112
Dissertation (99) 99
Conference Proceeding (93) 93
Web Resource (66) 66
Newsletter (41) 41
Newspaper Article (25) 25
Government Document (18) 18
Trade Publication Article (10) 10
Data Set (8) 8
Streaming Video (5) 5
Journal / eJournal (3) 3
Paper (2) 2
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (113189) 113189
humans (112035) 112035
adult (46325) 46325
middle aged (41867) 41867
index medicus (24607) 24607
aged (24493) 24493
uterine cervical neoplasms - pathology (24484) 24484
oncology (20274) 20274
obstetrics & gynecology (18209) 18209
cervical cancer (16938) 16938
cancer (15200) 15200
uterine cervical neoplasms - diagnosis (14791) 14791
pregnancy (13274) 13274
uterine neoplasms - pathology (11853) 11853
uterine cervical neoplasms - surgery (9176) 9176
uterine cervical neoplasms - virology (8999) 8999
carcinoma (8900) 8900
adolescent (8796) 8796
uterine cervical neoplasms - prevention & control (8672) 8672
vaginal smears (8625) 8625
neoplasm staging (8623) 8623
prognosis (8589) 8589
hysterectomy (8550) 8550
women (8463) 8463
uterine cervical neoplasms - radiotherapy (8425) 8425
retrospective studies (7866) 7866
uterine neoplasms - surgery (7772) 7772
male (7736) 7736
uterine cervical neoplasms - epidemiology (7496) 7496
risk factors (7004) 7004
pathology (6910) 6910
uterine neoplasms (6875) 6875
uterine cervical neoplasms (6709) 6709
animals (6382) 6382
uterine neoplasms - diagnosis (6033) 6033
carcinoma, squamous cell - pathology (5968) 5968
aged, 80 and over (5818) 5818
follow-up studies (5811) 5811
uterine cervical neoplasms - therapy (5627) 5627
human papillomavirus (5530) 5530
diagnosis (5518) 5518
treatment outcome (5415) 5415
neoplasms (5255) 5255
young adult (5251) 5251
uterine cervix (5172) 5172
uterine cervical neoplasms - genetics (5050) 5050
cervix uteri - pathology (4845) 4845
health aspects (4758) 4758
adenocarcinoma - pathology (4742) 4742
uterine cervical neoplasms - drug therapy (4720) 4720
immunohistochemistry (4710) 4710
radiotherapy (4593) 4593
risk (4587) 4587
uterine cervical neoplasms - metabolism (4562) 4562
surgery (4542) 4542
uterine cervical neoplasms - mortality (4459) 4459
research (4396) 4396
time factors (4369) 4369
diagnosis, differential (4359) 4359
biopsy (4304) 4304
uterus (4164) 4164
age factors (4134) 4134
radiology, nuclear medicine & medical imaging (4085) 4085
cervical intraepithelial neoplasia - pathology (4031) 4031
colposcopy (4028) 4028
papanicolaou test (3980) 3980
medicine, general & internal (3899) 3899
leiomyoma - surgery (3891) 3891
analysis (3845) 3845
mass screening (3766) 3766
papillomaviridae - genetics (3689) 3689
tumors (3686) 3686
obstetrics and gynecology (3663) 3663
papillomavirus infections - virology (3660) 3660
papillomaviridae - isolation & purification (3609) 3609
combined modality therapy (3571) 3571
expression (3561) 3561
papillomavirus infections (3530) 3530
sensitivity and specificity (3502) 3502
care and treatment (3498) 3498
uterine neoplasms - therapy (3487) 3487
uterine neoplasms - drug therapy (3473) 3473
prospective studies (3427) 3427
lymphatic metastasis (3414) 3414
uterine neoplasms - complications (3363) 3363
chemotherapy (3218) 3218
neoplasm invasiveness (3187) 3187
cervical intraepithelial neoplasia - virology (3157) 3157
prevalence (3141) 3141
public, environmental & occupational health (3109) 3109
mice (3103) 3103
leiomyoma - pathology (3050) 3050
cervix (3013) 3013
radiotherapy dosage (2939) 2939
papillomavirus infections - complications (2930) 2930
uterine cervical neoplasms - etiology (2842) 2842
adenocarcinoma (2816) 2816
papillomavirus infections - prevention & control (2770) 2770
papillomavirus infections - diagnosis (2767) 2767
cervix uteri (2750) 2750
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (121) 121
Online Resources - Online (63) 63
Collection Dvlpm't (Acquisitions) - Vendor file (13) 13
Collection Dvlpm't (Acquisitions) - Closed Orders (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (5) 5
New College (Ivey) - Stacks (3) 3
Scarborough Hospital - General (3) 3
Scarborough Hospital - Online (3) 3
Sunnybrook Health Sciences Centre - Sunnybrook Patient Education (2) 2
UTL at Downsview - May be requested (2) 2
UofT at Mississauga - Stacks (2) 2
Baycrest Hospital - Wellness Library (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Periodical Stacks (1) 1
Gerstein Science - Searching (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Markham Stouffville Hospital - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (93884) 93884
German (5534) 5534
French (3950) 3950
Japanese (3221) 3221
Russian (3076) 3076
Italian (2414) 2414
Spanish (2174) 2174
Chinese (1888) 1888
Polish (1486) 1486
Portuguese (766) 766
Czech (659) 659
Bulgarian (425) 425
Dutch (366) 366
Danish (282) 282
Hungarian (239) 239
Swedish (189) 189
Korean (185) 185
Norwegian (143) 143
Croatian (128) 128
Serbian (127) 127
Ukrainian (125) 125
Slovak (100) 100
Romanian (95) 95
Finnish (92) 92
Hebrew (73) 73
Turkish (32) 32
Slovenian (14) 14
Bosnian (10) 10
Lithuanian (10) 10
Afrikaans (7) 7
Arabic (5) 5
Persian (4) 4
Greek (3) 3
Icelandic (3) 3
Thai (2) 2
Esperanto (1) 1
Indonesian (1) 1
Latin (1) 1
Latvian (1) 1
Macedonian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 02/2013, Volume 105, Issue 3, pp. 175 - 201
The American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American... 
United States - epidemiology | Age Distribution | Asian Americans - statistics & numerical data | Humans | Uterine Cervical Neoplasms - epidemiology | Cost of Illness | Anus Neoplasms - virology | Hispanic Americans - statistics & numerical data | Male | Neoplasms - prevention & control | Cause of Death | Incidence | Indians, North American - statistics & numerical data | Penile Neoplasms - epidemiology | Neoplasms - virology | Neoplasms - ethnology | Female | Anus Neoplasms - epidemiology | Papillomavirus Vaccines - administration & dosage | Penile Neoplasms - virology | Papillomavirus Infections - complications | SEER Program | Papanicolaou Test | Papillomavirus Infections - epidemiology | Neoplasms - mortality | Papillomavirus Infections - ethnology | Vulvar Neoplasms - virology | Mortality - trends | Oropharyngeal Neoplasms - virology | Vaginal Neoplasms - virology | Vaginal Smears - statistics & numerical data | Alphapapillomavirus | Oropharyngeal Neoplasms - epidemiology | African Americans - statistics & numerical data | Oceanic Ancestry Group - statistics & numerical data | Vaginal Neoplasms - epidemiology | Adolescent | Vulvar Neoplasms - epidemiology | Sex Distribution | Uterine Cervical Neoplasms - virology | Neoplasms - epidemiology | Prevention | Control | Forecasts and trends | Papillomavirus infections | Patient outcomes | Mortality
Journal Article
Cancer Causes & Control, ISSN 0957-5243, 5/2009, Volume 20, Issue 4, pp. 417 - 435
Background Population-based cancer registry data from the Surveillance, Epidemiology, and End Results (SEER) Program at the National Cancer Institute (NCI) are... 
Socioeconomic status | Prophets | Mortality | Censuses | Cancer incidence | Breast cancer | Socioeconomics | Educational attainment | Lung neoplasms | Cancer | NLMS | SES | Poverty | Hematology | Rural/urban | Income | Oncology | Record linkage | Public Health/Gesundheitswesen | Epidemiology | Unemployment | Biomedicine general | Biomedicine | Education | Race/ethnicity | Cancer Research | SEER | Stage | Health disparities | RACIAL-DIFFERENCES | BREAST-CANCER | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | PROSTATE-CANCER | UNITED-STATES | CERVICAL-CANCER | RESULTS PROGRAM | US WOMEN | SOCIAL-CLASS | DEATH INDEX | ONCOLOGY | COLORECTAL-CANCER | Melanoma - epidemiology | Lung Neoplasms - ethnology | United States - epidemiology | Uterine Cervical Neoplasms - ethnology | Lung Neoplasms - mortality | Humans | Survivors - statistics & numerical data | Uterine Cervical Neoplasms - epidemiology | Lung Neoplasms - pathology | Male | Uterine Cervical Neoplasms - pathology | Incidence | Neoplasms - ethnology | Female | Registries | Medical Record Linkage | Breast Neoplasms - ethnology | Uterine Cervical Neoplasms - mortality | Breast Neoplasms - epidemiology | Ethnic Groups - statistics & numerical data | Prostatic Neoplasms - pathology | SEER Program | Melanoma - ethnology | Neoplasms - mortality | Prostatic Neoplasms - ethnology | Melanoma - pathology | Prostatic Neoplasms - mortality | Social Class | Prostatic Neoplasms - epidemiology | Lung Neoplasms - epidemiology | Breast Neoplasms - pathology | Healthcare Disparities | Breast Neoplasms - mortality | Neoplasm Staging | Neoplasms - pathology | Longitudinal Studies | Neoplasms - epidemiology | Cohort Studies | Melanoma - mortality | Social classes | Usage | Demographic aspects | Social aspects | Health aspects | Epidemiologic methods | Rural | ethnicity | Original Paper | urban | Race
Journal Article
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2016, Volume 66, Issue 4, pp. 271 - 289
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For... 
prevalence | survivorship | treatment patterns | statistics | LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | SELECTIVE BLADDER PRESERVATION | LONG-TERM SURVIVORS | BREAST-CONSERVING THERAPY | METASTATIC PROSTATE-CANCER | ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | COLORECTAL-CANCER | CARDIOVASCULAR-DISEASE | QUALITY-OF-LIFE | Uterine Neoplasms - therapy | United States - epidemiology | Prevalence | Humans | Middle Aged | Survivors - statistics & numerical data | Child, Preschool | National Cancer Institute (U.S.) | Infant | Male | Neoplasms - diagnosis | Incidence | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | American Cancer Society | Neoplasms - therapy | Skin Neoplasms - mortality | Aged, 80 and over | Uterine Neoplasms - mortality | Adult | Female | Registries | Child | Infant, Newborn | Colonic Neoplasms - therapy | Colonic Neoplasms - mortality | Skin Neoplasms - therapy | Risk Factors | Neoplasms - mortality | Survival Rate | Evidence-Based Medicine | Prostatic Neoplasms - mortality | Adolescent | Breast Neoplasms - mortality | Aged | Melanoma - therapy | Neoplasms - epidemiology | Melanoma - mortality | Care and treatment | Management | Primary health care | Analysis | Public health | Cancer | Survivor | Oncology | Family medical history | Disease management | Medical diagnosis | Medical statistics | Primary care
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2017, Volume 23, Issue 6, pp. 664 - 673
Neuroendocrine (NE) cancers are a diverse group of neoplasms typically diagnosed and treated on the basis of their site of origin. This Perspective focuses on... 
MOLECULAR CHARACTERIZATION | MEDICINE, RESEARCH & EXPERIMENTAL | PANCREATIC ENDOCRINE NEOPLASMS | TRANSGENIC MOUSE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ANTIANDROGEN RESISTANCE | CONDITIONAL MOUSE MODEL | AURORA KINASE | METASTATIC PROSTATE-CANCER | T-ANTIGEN | CELL BIOLOGY | CELL LUNG-CANCER | N-MYC | Lung Neoplasms - drug therapy | Colonic Neoplasms - genetics | Carcinoma, Small Cell - genetics | Colonic Neoplasms - drug therapy | Epigenesis, Genetic | Humans | Male | Antineoplastic Agents - therapeutic use | Molecular Targeted Therapy | Tumor Suppressor Protein p53 - genetics | Ovarian Neoplasms - genetics | Neoplasms, Glandular and Epithelial - genetics | Prostatic Neoplasms - genetics | Urinary Bladder Neoplasms - genetics | Female | Cell Differentiation | Retinoblastoma Binding Proteins - genetics | Ovarian Neoplasms - drug therapy | Prostatic Neoplasms - drug therapy | Triazoles - therapeutic use | Lung Neoplasms - genetics | Antibodies, Monoclonal, Humanized - therapeutic use | Carcinoma, Neuroendocrine - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinogenesis - genetics | Head and Neck Neoplasms - drug therapy | Carcinoma, Neuroendocrine - genetics | Uterine Cervical Neoplasms - drug therapy | Urinary Bladder Neoplasms - drug therapy | Uterine Cervical Neoplasms - genetics | Disease Progression | Azepines - therapeutic use | Neuroendocrine Tumors - genetics | Proto-Oncogene Proteins c-met - genetics | Cell Lineage | Cell Plasticity - genetics | Esophageal Neoplasms - genetics | Pyrimidines - therapeutic use | Neuroendocrine Tumors - drug therapy | Head and Neck Neoplasms - genetics | Proto-Oncogene Proteins c-myc - genetics | Ubiquitin-Protein Ligases - genetics | Benzodiazepines - therapeutic use | Esophageal Neoplasms - drug therapy | Proteins | Research | Health aspects | Carcinogenesis | Gastrin
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 03/2017, Volume 67, Issue 2, pp. 100 - 121
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2015, Volume 10, Issue 12, p. e0145754
Background High-grade serous ovarian and endometrial cancers are the most lethal female reproductive tract malignancies worldwide. In part, failure to treat... 
CA-125 | MULTIDISCIPLINARY SCIENCES | EPITHELIAL OVARIAN-CANCER | Endometrial Neoplasms - mortality | Humans | Middle Aged | Ovarian Neoplasms - mortality | Genital Neoplasms, Female - drug therapy | DNA, Neoplasm - blood | Endometrial Neoplasms - genetics | Adult | Female | Neoplasm Recurrence, Local - blood | Ovarian Neoplasms - drug therapy | Genital Neoplasms, Female - genetics | CA-125 Antigen - blood | Ovarian Neoplasms - blood | Genital Neoplasms, Female - blood | Mutation - genetics | Breast Neoplasms - drug therapy | Biomarkers, Tumor - blood | Genital Neoplasms, Female - mortality | Exome - genetics | Breast Neoplasms - genetics | Breast Neoplasms - blood | Breast Neoplasms - mortality | Endometrial Neoplasms - drug therapy | Neoplasm Recurrence, Local - genetics | Aged | Biomarkers, Tumor - genetics | DNA, Neoplasm - genetics | Endometrial Neoplasms - blood | Physiological aspects | Prognosis | Biological markers | Genital cancer | Tumors | Plasma | Scanning | Ovarian carcinoma | Medical services | Fallopian tube | Cancer therapies | Ovarian cancer | Gene sequencing | Computed tomography | Surgery | Quality | Imaging | Endometrium | Deoxyribonucleic acid--DNA | DNA probes | Gynecology | Breast cancer | Patients | Survival | Obstetrics | Medicine | Lead time | Chemotherapy | Surveillance | Womens health | Biomarkers | Diagnostic systems | Mutation | Reproductive system | Uterine cancer | Peritoneum | Cancer | Deoxyribonucleic acid | DNA
Journal Article